PA
BEAT

Perceptive Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Perceptive Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,369
Closed -$399K – 127
2019
Q1 		$399K Buy
+6,369
New +$437K 0.01% 96

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perceptive Advisors's BEAT Position: Q2 2019 in Review

Perceptive Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 6,369 shares — an estimated $399K sold.

Perceptive Advisors first reported a position in BEAT in Q1 2019 and held it in 1 quarter. The position peaked at $399K in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Perceptive Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Perceptive Advisors sold 6,369 BioTelemetry, Inc. shares in Q2 2019, an estimated $399K.
  • Perceptive Advisors first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 1 quarter.
  • Perceptive Advisors's BioTelemetry, Inc. position peaked at $399K in Q1 2019.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Perceptive Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.